$0.50
(Market cap
$262 Mln
Revenue (TTM)
$16 Mln
P/E Ratio
--
P/B Ratio
3.7
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-5.7
-
Debt to Equity
0.1
-
Book Value
$3
-
EPS
$1.4
-
Face value
--
-
Shares outstanding
36,293,640
10 Years Aggregate
CFO
$-150.63 Mln
EBITDA
$-165.13 Mln
Net Profit
$-187.91 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Profound Medical (PROF)
| -2.7 | 20.1 | 21.2 | 59.3 | -17.1 | -17.6 | -- |
|
BSE Sensex
| -8.7 | 3.6 | -7.5 | -4.2 | 8.2 | 9.5 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Profound Medical (PROF)
| 4.8 | -22.0 | -3.0 | -45.4 | 87.8 | 160.7 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Profound Medical (PROF)
|
7.7 | 262.0 | 16.4 | 42.3 | -260.2 | 55.9 | -- | 3.7 |
| 15.8 | 5,704.6 | 5,203.0 | -219.0 | 4.6 | -3.5 | -- | 0.9 | |
| 3.7 | 162.3 | 285.3 | -10.7 | -0.9 | -9.2 | -- | 1.6 | |
| 9.1 | 326.4 | 270.3 | 14.9 | 8.6 | 10.9 | 23 | 2.6 |
Shareholding Pattern
View DetailsAbout Profound Medical (PROF)
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO... system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada. Address: 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5 Read more
-
Chairman of the Board & CEO
Dr. Arun Swarup Menawat MBA, Ph.D.
-
Chairman of the Board & CEO
Dr. Arun Swarup Menawat MBA, Ph.D.
-
Headquarters
Mississauga, ON
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Profound Medical (PROF)
What is the current share price of Profound Medical Corp (PROF) Today?
The share price of Profound Medical Corp (PROF) is $7.66 (NASDAQ) as of 08-May-2026 10:34 EDT. Profound Medical Corp (PROF) has given a return of -17.09% in the last 3 years.
What is the current PB & PE ratio of Profound Medical Corp (PROF)?
Since, TTM earnings of Profound Medical Corp (PROF) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
5.58
|
2.59
|
|
2024
|
-7.09
|
3.11
|
|
2023
|
-6.24
|
5.71
|
|
2022
|
-7.98
|
4.40
|
|
2021
|
-7.32
|
2.79
|
What is the 52 Week High and Low of Profound Medical Corp (PROF)?
The 52-week high and low of Profound Medical Corp (PROF) are Rs 8.95 and Rs 3.76 as of 08-May-2026.
What is the market cap of Profound Medical Corp (PROF)?
Profound Medical Corp (PROF) has a market capitalisation of $ 262 Mln as on 07-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Profound Medical Corp (PROF)?
Before investing in Profound Medical Corp (PROF), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.